This application is the national phase under 35 U.S.C. .sctn.371 of PCT International Application No. PCT/KP98/00214 which has an International filing date of Jul. 15, 1998, which designated the United States of America.
TECHNICAL FIELD
The present invention relates to a pharmaceutical composition